Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
02/2011
02/09/2011EP2281003A1 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof
02/09/2011EP2281002A2 Anti-alk1 antibodies and uses thereof
02/09/2011EP2281001A1 Anti-areg/hb-egf antibodies and treatment
02/09/2011EP2281000A2 Antibody purification process
02/09/2011EP2280999A1 Process for producing milk fractions rich in secretory immunoglobulins
02/09/2011EP2280998A1 Methods for manufacturing a polyclonal protein
02/09/2011EP2280997A2 Human equivalent monoclonal antibodies engineered from nonhuman variable regions
02/09/2011EP2280732A2 Antibodies to granulocyte-macrophage colony-stimulating factor
02/09/2011EP2280731A1 Anti human immunodeficiency antibodies and uses thereof
02/09/2011EP1877439B1 Il-21 variants
02/09/2011EP1765395B1 Anti-gluten egg yolk antibodies for the treatment of celiac disease
02/09/2011EP1725659B1 Natural igm antibodies and inhibitors thereof
02/09/2011EP1636561B1 Combinatorial protein library screening by periplasmic expression
02/09/2011EP1311680B1 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor
02/09/2011EP1280898B1 Modified es cells and es cell-specific gene
02/09/2011EP1100929B1 Identification and functional characterization of a novel ribosomal s6 protein kinase
02/09/2011EP0986577B1 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
02/09/2011EP0848755B2 Vegf-related protein
02/09/2011EP0668777B2 Prostate-specific membrane antigen
02/09/2011CN1882602B The modulation of hyaluronan synthesis and degradation in the treatment of disease
02/09/2011CN1867585B Fully human antibodies against human 4-1BB (CD137)
02/09/2011CN101971023A Method of discriminating bovine, thus discriminated bovine and kit for discriminating bovine
02/09/2011CN101970670A Methods for inhibiting angiogenesis using egfl8 antagonists
02/09/2011CN101970666A Fusion protein that directs vaccine antigens to antigen-presenting cells, and applications thereof
02/09/2011CN101970500A Anti-tyrp1 antibodies
02/09/2011CN101970499A Monoclonal antibodies for tumor treatment
02/09/2011CN101970498A Antibodies against a cancer-associated epitope of variant hnrnpg and uses thereof
02/09/2011CN101970497A Anti-epcam antibody and uses thereof
02/09/2011CN101970496A Antibody against the csf-1 r
02/09/2011CN101970495A Use of substances for sensitization of tumor cells to radiation and/or chemotherapy
02/09/2011CN101970494A Humanized anti-c5ar antibodies
02/09/2011CN101970493A A monoclonal antibody and a method thereof
02/09/2011CN101970492A Fc variants with altered binding to fcrn
02/09/2011CN101970491A Dendritic cell marker and uses thereof
02/09/2011CN101970490A Amino acid sequences directed against heterodimeric cytokines and/or their receptors and polypeptides comprising the same
02/09/2011CN101970489A Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same
02/09/2011CN101970488A Humanized antibody molecules specific for il-31
02/09/2011CN101970487A Antibodies to gdf8 as uses thereof
02/09/2011CN101970486A Antibodies specific to pro-angiogenic isoforms of vascular endothelial growth factor (vegf)
02/09/2011CN101970485A Heparin-binding epidermal growth factor-like growth factor antigen binding proteins
02/09/2011CN101970484A Antigen binding proteins
02/09/2011CN101970483A Antibodies against influenza virus and methods of use thereof
02/09/2011CN101970482A Identification of antigen- or ligand-specific binding proteins
02/09/2011CN101970478A Modulation of sirpalphalpha - cd47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor
02/09/2011CN101970468A Component protein pa1698 for type-iii secretion system of pseudomonas aeruginosa
02/09/2011CN101970456A Tag peptide and use thereof
02/09/2011CN101970006A Alpha 5 - beta 1 antibodies and their uses
02/09/2011CN101970004A Methods for using and identifying modulators of delta-like 4
02/09/2011CN101970002A Method of inhibiting complement activation with factor bb specific antibodies
02/09/2011CN101970000A Prevention and treatment of cerebral amyloid angiopathy
02/09/2011CN101969992A Gas57 mutant antigens and gas57 antibodies
02/09/2011CN101969988A Immunotherapy regimes dependent on apoe status
02/09/2011CN101969976A Polypeptide vaccine and vaccination strategy against mycobacterium
02/09/2011CN101968488A Colloidal gold fast diagnostic test strip of goose paramyxovirus disease
02/09/2011CN101968487A Immune colloidal gold test paper for detecting listeria hemolysin and preparation method thereof
02/09/2011CN101968481A Method for detecting existence of heavy metal copper ion in sample and special kit thereof
02/09/2011CN101967490A Xylanases, nucleic adics encoding them and methods for making and using them
02/09/2011CN101967472A RBP4 hybridoma cell strain and preparation method and application thereof
02/09/2011CN101967465A Retinol binding protein (RBP) monoclonal antibody and hybridoma cells, preparation method and application thereof
02/09/2011CN101967191A Preparation method of HLA-G (Human Leukocyte Antigen G) antibody and application of HLA-G antibody in medicine
02/09/2011CN101967190A Method of detecting probnp with a monoclonal antibody binding to the amino acids 38-44 of probnp
02/09/2011CN101967189A RBP4 (Retinol Binding Protein 4) monoclonal antibody and hybridoma cells thereof as well as preparation method and applications thereof
02/09/2011CN101967184A Prokaryotic expressed protein of coat protein gene of cymbidium mosaic virus, preparation method and application thereof
02/09/2011CN101966338A Method of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular agonist
02/09/2011CN101966337A Genetic products differentially expressed in tumors and the use thereof
02/09/2011CN101200728B Unsaturated fatty acid synthase gene originating in marchantiales plant and utilization of the same
02/08/2011US7884198 The antibodies bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal infection in vivo
02/08/2011US7884193 Antibodies for identification of murine fragilis extracellular domain and methods for identifying pluripotent cells
02/08/2011US7884190 Recombinant dimeric and heterodimeric proteins comprising amino acids 193 to 252 of the β chain of the human C4BP protein
02/08/2011US7884184 comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region; suppressing an antigen-specific immune response to a target antigen; Autoimmune disease
02/08/2011US7884180 binds formyl peptide receptor-like 1 (FPRL1); useful for treating disorders associated with G-protein coupled receptor activation
02/08/2011US7884179 monoclonal antibodies or antigen binding fragments that specifically to six transmembrane epithelial antigens of the prostate (STEAP-1), used for medical diagnosis, prognosis, prophylaxis and/or therapy for cancers
02/08/2011US7884178 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use
02/08/2011US7884054 Methods for identifying functional antibodies
02/08/2011US7883896 for early diagnosis, prognosis and monitoring of the disease course and for therapy and vaccination of cell proliferative disorders such as lung adenocarcinoma, lung carcinoma
02/08/2011US7883880 DNA polymerase lambda and uses thereof
02/08/2011US7883868 Nucleotide sequences coding beta -10 glycoprotein hormone use in diagnosis and prevention of thyroid gland disorders
02/08/2011US7883857 CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
02/08/2011US7883855 Immunosuppressant drug extraction reagent for immunoassays
02/08/2011US7883853 Diagnosis of hepatocellular carcinoma
02/08/2011US7883704 Methods for inhibiting the activity of the P40 subunit of human IL-12
02/08/2011US7883703 Methods of modulating immunity
02/08/2011US7883702 Use of anti-mortalin 2 antibody and functional nucleic acid for cancer therapies
02/08/2011US7883701 Administering to animal an agent that can reduce the formation of the signal transduction complex of endotoxin, toll-like receptor 4 (TLR4) and CD14 on the cellular surface of a cell in the gastrointestinal tract of the animal
02/08/2011CA2370466C Methods of treatment using anti-erbb antibody-maytansinoid conjugates
02/08/2011CA2328321C Combination vaccine for enhancing immunity against brucellosis
02/08/2011CA2325566C Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates
02/08/2011CA2295971C Pseudomonas exotoxin a-like chimeric immunogens
02/08/2011CA2220830C Novel human cyclin-dependent kinase-like proteins and methods of using the same
02/08/2011CA2210467C Osteoprotegerin
02/08/2011CA2199940C Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites
02/08/2011CA2184059C Human trk receptors and neurotrophic factor inhibitors
02/08/2011CA2164226C Methods for selectively stimulating proliferation of t cells
02/03/2011WO2011014750A1 Inhibition of tumor metastasis using bv8- or g-csf-antagonists
02/03/2011WO2011014679A1 Method and kit for treating nicotine addiction
02/03/2011WO2011014671A1 Polypeptides that bind tissue inhibitor of metalloproteinase type three (timp-3), compositions and methods
02/03/2011WO2011014659A2 Dual variable domain immunoglobulins and uses thereof
02/03/2011WO2011014469A1 High affinity human antibodies to human angiopoietin-2
02/03/2011WO2011014457A1 Combination treatments
02/03/2011WO2011014438A1 Fully human antibodies to btla